Jeffrey Humphrey - Oct 1, 2021 Form 4 Insider Report for Magenta Therapeutics, Inc. (MGTA)

Role
Chief Medical Officer
Signature
/s/ Thomas W. Beetham, Attorney-in-Fact for Jeffrey Humphrey
Stock symbol
MGTA
Transactions as of
Oct 1, 2021
Transactions value $
$0
Form type
4
Date filed
10/4/2021, 04:34 PM
Previous filing
Jul 19, 2021
Next filing
Dec 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTA Stock Option (Right to Buy) Award $0 +275K $0.00 275K Oct 1, 2021 Common Stock 275K $7.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exerciseable over four years, with 25% of this option vesting on October 1, 2022, and the remainder vesting in 36 equal monthly installments thereafter.